Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of FTY720 in Kidney Transplantation
NCT00098735Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fingolimod in kidney transplant rejection, sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
fingolimod
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00098735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098735.